Should we limit antiarrhythmic drug choice in patients with left ventricular hypertrophy?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Should we limit antiarrhythmic drug choice in patients with left ventricular hypertrophy?

Published:2022-11-09 Issue:2 Volume:34 Page:453-454
ISSN:1045-3873
Container-title:Journal of Cardiovascular Electrophysiology
language:en
Short-container-title:Cardiovasc electrophysiol

Author:

Naccarelli Gerald V.¹^ORCID,Kowey Peter R.²³

Affiliation:

1. The Milton S. Hershey Medical Center, Penn State Heart and Vascular Institute Penn State University College of Medicine Hershey Pennsylvania USA

2. Lankenau Heart Institute Wynnewood Pennsylvania USA

3. Thomas Jefferson University Philadelphia Pennsylvania USA

Publisher

Wiley

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jce.15732

Reference20 articles.

1. The Association Between Left Ventricular Hypertrophy and the Occurrence and Prognosis of Atrial Fibrillation: A Meta-Analysis

2. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death

3. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary

4. Mechanisms of Arrhythmias in Ventricular Hypertrophy

5. Canine left ventricular hypertrophy predisposes to ventricular tachycardia induction by phase 2 early afterdepolarizations after administration of BAY K 8644

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP